申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0299761A1
公开(公告)日:1989-01-18
The present invention provides compounds of formula (II)
wherein
q is 1, k is 0, and p is 1;
Ar is phenyl optionally substituted by one or more substituents independently selected from C₁₋₄ alkyl (which may be substituted by one or more halogen atoms) and halogen;
L is -0-;
Ar′ is 1,3- or 1,4-phenylene;
Y is (E)-CH=CH-;
V is hydrogen or C₁₋₄ alkyl;
W is C₁₋₄ alkyl; and
Q is a moiety of formula
wherein m is 1, R¹ is hydrogen, and R² is hydrogen or C₁₋₄ alkyl;
and salts thereof, processes for the preparation of these compounds, pharmaceutical formulations containing them, and uses for them in medicine and in other applications.
本发明提供了式 (II) 的化合物
其中
q 是 1,k 是 0,p 是 1;
Ar 是任选被一个或多个取代基取代的苯基,这些取代基独立选自 C₁₋₄ 烷基(可被一个或多个卤原子取代)和卤素;
L 是-0-;
Ar′ 是 1,3- 或 1,4-亚苯基;
Y 是 (E)-CH=CH-;
V 是氢或 C₁₋₄ 烷基;
W 是 C₁₋₄ 烷基;以及
Q 是式中的分子
其中m为1,R¹为氢,R²为氢或C₁₋₄烷基;
及其盐类、这些化合物的制备工艺、含有这些化合物的药物制剂,以及这些化合物在医学和其他应用中的用途。